Dan Lemaitre
CIK 1478479 · last filed 2026-01-23
Dan Lemaitre is a corporate insider who has filed 38 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing, for GMED, was dated Jan 23, 2026. Across all open-market trades the lifetime net is −$8.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
38
-$8.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Director | 0 | $80.39 | $0 | -$8.75M | 22 | 2026-01-23 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 54,097 | — | — | $99.8K | 14 | 2019-10-01 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | GMED | Grant (A) | — | $0 | EDGAR |
| 2025-03-28 | GMED | Grant (A) | — | $0 | EDGAR |
| 2024-11-25 | GMED | Mixed | — | -$286.8K | EDGAR |
| 2024-05-14 | GMED | Mixed | −10,800 | -$1.63M | EDGAR |
| 2024-01-30 | GMED | Grant (A) | — | $0 | EDGAR |
| 2023-05-17 | GMED | Mixed | — | -$1.37M | EDGAR |
| 2023-02-27 | GMED | Grant (A) | — | $0 | EDGAR |
| 2023-02-13 | GMED | Exer (M) | +5,550 | $132.9K | EDGAR |
| 2023-01-30 | GMED | Exer (M) | +5,250 | $66.1K | EDGAR |
| 2023-01-18 | GMED | Other (J) | — | $0 | EDGAR |